SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-22-073922
Filing Date
2022-06-23
Accepted
2022-06-23 16:31:19
Documents
1
Period of Report
2022-05-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2219215-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2219215-1_3seq1.xml 3 3256
  Complete submission text file 0001104659-22-073922.txt   4742
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Issuer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address OFFICE 2458, FLOOR 24, AL-SILA TOWER ABU DHABI C0 00000
Business Address
Al-Nahyan Tahnoon Bin Zayed S. (Reporting) CIK: 0001934660 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37524 | Film No.: 221035881